APT Medical proudly announces a groundbreaking achievement in Indonesia with the successful completion of the first pulsed-field atrial fibrillation (AF) ablation procedures at RSCM Hospital, Jakarta. Led by Prof. Yao Yan, alongside Dr. Muhammad Yamin and Dr. Simon Salim, the procedures were guided by the APT HT Viewer® 3D Mapping Platform—marking a significant milestone in the treatment of AF with the latest in innovative medical technology.

The cases involved some of the most complex clinical challenges, including long-persistent AF with atrial dilation, post-valvular surgery scar-related atrial tachycardia (AT), and severe heart failure. By leveraging precise mapping and cutting-edge PFA technology, all patients achieved optimal procedural endpoints with restored sinus rhythm.

Reflecting on the experience, Dr. Simon Salim commented: “The system is good, with clear signals. Very simple even for beginners to learn… HT Viewer combines EP recording and 3D mapping in one platform. The catheters are compatible with other brands. I will recommend it to other physicians.”

This milestone underscores not only the effectiveness of the HT Viewer® 3D Mapping Platform but also showcases the potential of PFA technology in addressing some of the most difficult cases of atrial fibrillation. The precision and efficacy of the APT HT Viewer® 3D Mapping Platform, combined with the strength of our advanced PFA technology, help to improve outcomes for AF patients.

Following the successful treatments, Prof. Yao presented a keynote speech titled "The Challenge of AF Ablation and the Role of PFA" at the JAKC-RHYTHM International Meeting, emphasizing the transformative role of PFA in AF ablation and sharing valuable perspectives on the global development of "Chinese innovative solutions" in atrial fibrillation procedures.

This momentous achievement marks the debut of China’s PFA technology on the global stage, reinforcing APT Medical’s unwavering commitment to advancing healthcare solutions that improve patient outcomes. As we continue to push the boundaries of innovation, we remain dedicated to collaborating with medical professionals worldwide to provide cutting-edge treatments for arrhythmia patients.